Clinical trial a Unani medicine for the treatment of patients with less mouth opening due to mucosal thickening
Not Applicable
- Conditions
- Health Condition 1: K135- Oral submucous fibrosis
- Registration Number
- CTRI/2023/11/060251
- Lead Sponsor
- Dr Arvind Kumar Kairo
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Age greater than or equal to 18 years , either gender.
2. Treatment naive patients diagnosed with stage 1,2 and 3 OSF.
3. Stage 1 OSF > 35 mm with other clinical features of OSF.
4. Stage 2 OSF -26-35 mm
5. Stage 3 OSF -15-26 mm
6. Patients who will give consent and agree to continue follow up for 1 year.
Exclusion Criteria
1. Histopathological evidence of premalignant conditions, dysplasia, malignancy or systemic diseases causing burning sensation of mouth, ulceration or reduction in mouth opening like systemic ulceration.
2. Patients suffering from medically compromised conditions like tuberculosis, HIV, renal and hepatic diseases etc.
3. Pregnant and lactating women.
4. Patients with history of intake drugs known to cause fibrosis.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method